https://mtimes.net/article/1451 MTIMES Global en 2026-11-05T04:02:48.140Z HLB's Next-Gen CAR-T Therapy Challenges Toxicity Limits with 60% Complete Remission in Blood Cancer Patients https://mtimes.net/article/1449 MTIMES Global en 2026-11-05T00:49:27.989Z US Midterms’ ‘Blue Tsunami’ Disrupts AI Momentum; Battery and Renewable Stocks Gain While Biotech Focuses on Yields https://mtimes.net/article/1442 MTIMES Global en 2026-11-04T02:26:51.167Z K-Defense Faces 65% Europe Wall: High Quality Not Enough as Local Production Becomes Mandatory https://mtimes.net/article/1452 MTIMES Global en 2026-11-05T05:58:34.892Z Citi Forecasts Global Memory Supply Deficit to Persist Through 2027 Despite Capacity Expansion https://mtimes.net/article/1445 MTIMES Global en 2026-11-04T07:38:35.101Z KOSPI Buffeted by US Midterms as Brokerages Split on Timing of Market Rebound https://mtimes.net/article/1430 MTIMES Global en 2026-11-02T22:37:22.441Z Amazon and SpaceX Battle for Frequencies in $45 Billion Space Internet Race https://mtimes.net/article/1436 MTIMES Global en 2026-11-03T06:27:46.868Z Korean Steelmakers Smile on North American LNG Investments, Prompting U.S. Pushback as Imports Surge 44% https://mtimes.net/article/1426 MTIMES Global en 2026-11-02T08:35:42.758Z AI Investment Boom Diverges Cash Flows, Testing Big Tech Financing Capacities https://mtimes.net/article/1410 MTIMES Global en 2026-11-01T03:17:17.179Z KOSDAQ under siege: Calls mount for short-selling ban and growth-tailored regulations https://mtimes.net/article/1412 MTIMES Global en 2026-11-01T23:00:41.830Z Is Wall Street’s 100% Win Rate Ahead of the Midterms Real? Analyzing the Statistics https://mtimes.net/article/1414 MTIMES Global en 2026-11-01T23:42:41.204Z South Korea’s October Exports Surge 34% Excluding Semiconductors, Led by Double-Digit Growth in Electrical Equipment and Cosmetics https://mtimes.net/article/1241 MTIMES Global en 2026-10-15T00:54:49.439Z Big Insight: Assessing the Market Impact of the September U.S. CPI Report https://mtimes.net/article/1214 MTIMES Global en 2026-10-12T23:51:43.945Z Mezzion Pharma Targets First-ever Fontan Treatment Approval, Leveraging Clinical Expertise for Global Commercialization https://mtimes.net/article/1162 MTIMES Global en 2026-10-06T22:55:31.843Z HLB Therapeutics CEO An Ki-hong: “RGN-259 Set to Become First-Line Choice for Neurotrophic Keratitis” https://mtimes.net/article/1146 MTIMES Global en 2026-10-05T21:42:37.847Z Global Phase 3 Watch: HLB Therapeutics Eyes $1.7B U.S. Neurotrophic Keratitis Market with November RGN-259 Readout https://mtimes.net/article/1141 MTIMES Global en 2026-10-03T02:18:40.463Z [K-Bio Global Phase 3] Fred Kim, Head of AriBio US: "AR1001 Aims to Become the First-Line Therapy for Early Alzheimer’s" https://mtimes.net/article/1135 MTIMES Global en 2026-10-02T08:03:16.376Z ARBIOW's AR1001 Aims for November Milestone as Commercialization Pace Quickens https://mtimes.net/article/1128 MTIMES Global en 2026-10-02T00:05:00.829Z KOSPI Edges Up, Yet 7 in 10 Stocks Fall as Semiconductor Concentration Deepens https://mtimes.net/article/1117 MTIMES Global en 2026-09-30T23:01:34.700Z Beyond Micron’s Strong Earnings: Long-Term Supply Contracts Rush in Through 2031 https://mtimes.net/article/1113 MTIMES Global en 2026-09-30T09:33:40.115Z AI Works Even When the App is Closed: Big Tech Shifts Focus to Persistent Autonomous Agents https://mtimes.net/article/1348 MTIMES Global en 2026-10-26T21:48:11.893Z HanAll Biopharma’s Batoclimab Wins Approval in China; Next-Gen Antibody Progresses to Global Phase 3 Trials https://mtimes.net/article/1454 MTIMES Global en 2026-11-05T07:35:22.453Z Korea Aerospace Industries Secures Undisclosed Major Export Deal Amid Speculation Over Aircraft Type https://mtimes.net/article/1456 MTIMES Global en 2026-11-05T08:09:18.292Z Samsung Maintains Lead in Global DRAM Market as SK hynix Closes the Gap; Battle Shifts to HBM4 https://mtimes.net/article/1431 MTIMES Global en 2026-11-02T23:09:52.497Z Potential Stake Reversal at Hanjin Kal: Three Hurdles Facing Hoban Group https://mtimes.net/article/1441 MTIMES Global en 2026-11-04T01:07:04.381Z AMD Posts Record Q3 as Data Center Revenue Surges 97%, Guides Q4 Above Consensus https://mtimes.net/article/1420 MTIMES Global en 2026-11-02T04:47:16.797Z Hanhan Breaches US Warship Market with Philly Shipyard Acquisition and $5B Expansion Plan https://mtimes.net/article/1408 MTIMES Global en 2026-11-01T00:44:02.307Z Anthropic Expands AI Business into Drug Discovery, from Antibody Optimization to Clinical Support https://mtimes.net/article/1439 MTIMES Global en 2026-11-03T23:21:04.608Z HLB Liver Cancer Drug Enters US FDA Review; Second Commercialization Milestone Set for April Next Year https://mtimes.net/article/1450 MTIMES Global en 2026-11-05T02:53:26.322Z DnD Pharmatech to Showcase Next-Gen Obesity Drug https://mtimes.net/article/1425 MTIMES Global en 2026-11-02T08:09:44.930Z POSCO Holdings Secures W2.5 Trillion War Chest, Accelerates Lithium Investment and Shareholder Returns https://mtimes.net/article/1396 MTIMES Global en 2026-10-30T02:34:19.895Z Hanmi Semiconductor Faces Earnings Miss Despite HBM Boom https://mtimes.net/ja/article/1451 MTIMES Global ja 2026-11-05T04:02:48.140Z HLBイノベーション、「奇跡の抗がん剤」CAR-T毒性限界を超えて…効能・安全性確認 https://mtimes.net/ja/article/1449 MTIMES Global ja 2026-11-05T00:49:27.989Z 美「ブルー津波」に揺れたAI独走…バッテリー・新再生浮上、バイオは金利注目 https://mtimes.net/ja/article/1442 MTIMES Global ja 2026-11-04T02:26:51.167Z K防山、武器は作っても売れない？欧州製65％の壁に阻まれる輸出の道 https://mtimes.net/ja/article/1452 MTIMES Global ja 2026-11-05T05:58:34.892Z シティ、2027年のメモリ供給不足を予測…増産でも需給不均衡が継続 https://mtimes.net/ja/article/1445 MTIMES Global ja 2026-11-04T07:38:35.101Z 米中間選挙に出たコスピ…証券家の反時計はそれぞれ https://mtimes.net/ja/article/1430 MTIMES Global ja 2026-11-02T22:37:22.441Z 天空のインターネットに45兆ウォン賭けるアマゾン・スペースX、周波数争奪戦 https://mtimes.net/ja/article/1436 MTIMES Global ja 2026-11-03T06:27:46.868Z 北米のLNG投資に沸くK製鉄、韓国産が44%急増でアメリカが牽制へ https://mtimes.net/ja/article/1426 MTIMES Global ja 2026-11-02T08:35:42.758Z AI投資競争で分かれるキャッシュフロー…ビッグテックの資金調達が試練に https://mtimes.net/ja/article/1410 MTIMES Global ja 2026-11-01T03:17:17.179Z 危機に直面するKOSDAQ…空売り禁止の請願、成長市場に合致する基準を要求 https://mtimes.net/ja/article/1412 MTIMES Global ja 2026-11-01T23:00:41.830Z [Big Insight - メル] 今投資すれば米株は勝率100%って本当か？ https://mtimes.net/ja/article/1414 MTIMES Global ja 2026-11-01T23:42:41.204Z 半導体以外の輸出も34%増、電気機器・化粧品が2桁成長 https://mtimes.net/ja/article/1241 MTIMES Global ja 2026-10-15T00:54:49.439Z [ビッグインサイト-メル] 9月CPIが発表された。結果を徹底分析する https://mtimes.net/ja/article/1214 MTIMES Global ja 2026-10-12T23:51:43.945Z 【Kバイオグローバル第3相 | 企画5】メジオン、初のフォンタン術治療薬に挑戦…臨床経験を商業化の競争力に https://mtimes.net/ja/article/1162 MTIMES Global ja 2026-10-06T22:55:31.843Z [Kバイオ グローバル第3相 | 企画4] HLBテラピューティクス代表 アン・ギホン「RGN-259、神経栄養性角膜炎（NK）初期治療の第1選択肢に期待」 https://mtimes.net/ja/article/1146 MTIMES Global ja 2026-10-05T21:42:37.847Z 【Kバイオ グローバル第3相｜企画3】HLBセラピューティクス、米2.3兆ウォン規模のNK治療薬市場に挑戦…11月にRGN-259の米国第3相結果に注目 https://mtimes.net/ja/article/1141 MTIMES Global ja 2026-10-03T02:18:40.463Z 【Kバイオ グローバル第3相｜企画2】アリバイオ米州支社長フレッド・キム氏「AR1001、初期アルツハイマーの1次治療薬を目指す」 https://mtimes.net/ja/article/1135 MTIMES Global ja 2026-10-02T08:03:16.376Z 【Kバイオ グローバル第3相 | 企画1】アーリバイオ「AR1001」、11月に成績表公開へ…商業化準備に拍車 https://mtimes.net/ja/article/1128 MTIMES Global ja 2026-10-02T00:05:00.829Z KOSPIは上昇も10社中7社が下落、再び強まる「半導体偏重」 https://mtimes.net/ja/article/1117 MTIMES Global ja 2026-09-30T23:01:34.700Z マイクロンの好業績の裏に一段と強いシグナル…2031年物量まで長期契約の「ラッシュ」 https://mtimes.net/ja/article/1113 MTIMES Global ja 2026-09-30T09:33:40.115Z 「アプリを閉じてもAIは働く」…ビッグテック、今度は「常時稼働型エージェント」で競争 https://mtimes.net/ja/article/1348 MTIMES Global ja 2026-10-26T21:48:11.893Z [Kバイオグローバル三相|企画6] ハンオルバイオファーマ、バトクリマブが中国で承認取得…次世代抗体はグローバル試験第3相を進行 https://mtimes.net/ja/article/1454 MTIMES Global ja 2026-11-05T07:35:22.453Z 한국항공우주, 베일에 싸인 새 수출 계약…다음 목적지는 어디 https://mtimes.net/ja/article/1456 MTIMES Global ja 2026-11-05T08:09:18.292Z サムスンがDRAM首位維持、SKハイニックスが猛追…HBM4で逆転競争へ https://mtimes.net/ja/article/1431 MTIMES Global ja 2026-11-02T23:09:52.497Z 韓진カル株式の持ち分逆転の可能性…ホバンの前に立ちはだかる3つの壁 https://mtimes.net/ja/article/1441 MTIMES Global ja 2026-11-04T01:07:04.381Z AMD、データセンター売上高97%急増…第4四半期は170億ドルを予測 https://mtimes.net/ja/article/1420 MTIMES Global ja 2026-11-02T04:47:16.797Z ハンファ、米軍艦市場に進出…50億ドルの投資で米造船業の規模を拡大 https://mtimes.net/ja/article/1408 MTIMES Global ja 2026-11-01T00:44:02.307Z アンソロピック、新薬開発でAI事業を拡大へ…抗体最適化から臨床支援まで https://mtimes.net/ja/article/1439 MTIMES Global ja 2026-11-03T23:21:04.608Z HLBの肝がん新薬、米FDAの本審査入り…来年4月に2度目の商業化の分水嶺 https://mtimes.net/ja/article/1450 MTIMES Global ja 2026-11-05T02:53:26.322Z ディアンディパマテック、「BIO-Europe 2026」参加… UCN2 ターゲット DD18 などグローバル・パートナーリングの議論 https://mtimes.net/ja/article/1425 MTIMES Global ja 2026-11-02T08:09:44.930Z ポスコホールディングス、2.5兆ウォンの手元資金確保…リチウム投資・株主還元を加速 https://mtimes.net/ja/article/1396 MTIMES Global ja 2026-10-30T02:34:19.895Z 漢美半導体、HBM好況下でアーニングショック…第4四半期の反発はあるか https://mtimes.net/zh/article/1451 MTIMES Global zh-cn 2026-11-05T04:02:48.140Z HLB Innovation，“抗癌神药”CAR-T突破毒性极限……有效性和安全性得到证实 https://mtimes.net/zh/article/1449 MTIMES Global zh-cn 2026-11-05T00:49:27.989Z 美“蓝色浪潮”撼动AI独走…电池与新能源受瞩目，生物医药聚焦利率走势 https://mtimes.net/zh/article/1442 MTIMES Global zh-cn 2026-11-04T02:26:51.167Z 即使你造出了好武器，也卖不出去？……欧洲产品65%壁垒封锁了出口路线 https://mtimes.net/zh/article/1452 MTIMES Global zh-cn 2026-11-05T05:58:34.892Z 花旗预计2027年内存供应短缺…增产难解供需失衡 https://mtimes.net/zh/article/1445 MTIMES Global zh-cn 2026-11-04T07:38:35.101Z 美 중간선거에 출렁인 综合股价指数(KOSPI)…증권가 반등 시계는 제각각 https://mtimes.net/zh/article/1430 MTIMES Global zh-cn 2026-11-02T22:37:22.441Z 押注45万亿韩元布局太空互联网：亚马逊与SpaceX掀起频谱争夺战 https://mtimes.net/zh/article/1436 MTIMES Global zh-cn 2026-11-03T06:27:46.868Z 笑对北美LNG投资的韩国钢铁：韩产增幅达44%引来美国 牵制 https://mtimes.net/zh/article/1426 MTIMES Global zh-cn 2026-11-02T08:35:42.758Z AI投资竞争致现金流分化：巨头资金筹措能力迎来试金石 https://mtimes.net/zh/article/1410 MTIMES Global zh-cn 2026-11-01T03:17:17.179Z 陷入危机的KOSDAQ…禁空令请愿频发，市场呼吁契合成长特性的监管标准 https://mtimes.net/zh/article/1412 MTIMES Global zh-cn 2026-11-01T23:00:41.830Z [Big Insight-Mer] 传闻现在投资美股胜率100%？这究竟是不是真的？ https://mtimes.net/zh/article/1414 MTIMES Global zh-cn 2026-11-01T23:42:41.204Z 除半导体外出口额也增长34% 电气设备与化妆品实现两位数增长 https://mtimes.net/zh/article/1241 MTIMES Global zh-cn 2026-10-15T00:54:49.439Z [Big Insight-Mer] 9月CPI数据出炉：深度解析核心结果 https://mtimes.net/zh/article/1214 MTIMES Global zh-cn 2026-10-12T23:51:43.945Z 【K-Bio全球三期 | 策划5】Mezzion挑战首款Fontan术治疗药物…以临床经验转化为商业化竞争力 https://mtimes.net/zh/article/1162 MTIMES Global zh-cn 2026-10-06T22:55:31.843Z [K-Bio全球III期临床 | 策划4] HLB Therapeutics代表安基洪：“期待RGN-259成为NK初期治疗的首选方案” https://mtimes.net/zh/article/1146 MTIMES Global zh-cn 2026-10-05T21:42:37.847Z 【K-Bio全球III期临床｜策划3】HLB Therapeutics进军美国2.3万亿韩元NK治疗药物市场…11月RGN-259美国III期临床结果备受瞩目 https://mtimes.net/zh/article/1141 MTIMES Global zh-cn 2026-10-03T02:18:40.463Z 【K-Bio全球III期临床｜策划2】阿里拜尔（AｒｉBio）美洲支社长Fred Kim：“AR1001旨在成为早期阿尔茨海默病一线治疗药物” https://mtimes.net/zh/article/1135 MTIMES Global zh-cn 2026-10-02T08:03:16.376Z 【K-Bio全球三期临床 | 策划1】ArisBio AR1001将于11月揭晓成绩单……商业化准备加速 https://mtimes.net/zh/article/1128 MTIMES Global zh-cn 2026-10-02T00:05:00.829Z KOSPI上涨但十分之七个股下跌，“半导体独大”现象再度加剧 https://mtimes.net/zh/article/1117 MTIMES Global zh-cn 2026-09-30T23:01:34.700Z 美光强劲财报背后的更强信号：长期合约“涌向”2031年交付量 https://mtimes.net/zh/article/1113 MTIMES Global zh-cn 2026-09-30T09:33:40.115Z “关掉App，AI也在干活”……科技巨头竞逐“常驻型代理” https://mtimes.net/zh/article/1348 MTIMES Global zh-cn 2026-10-26T21:48:11.893Z [K-生物医药全球三期 | 策划6] 韩올生物医药파마 Batoclimab获中国批准…次代抗体正在推进全球三期临床 https://mtimes.net/zh/article/1454 MTIMES Global zh-cn 2026-11-05T07:35:22.453Z 한국항공우주, 베일에 싸인 새 수출 계약…다음 목적지는 어디 https://mtimes.net/zh/article/1456 MTIMES Global zh-cn 2026-11-05T08:09:18.292Z 三星DRAM稳居第一，SK海力士猛追…HBM4竞争进入逆转阶段 https://mtimes.net/zh/article/1431 MTIMES Global zh-cn 2026-11-02T23:09:52.497Z 韩进KAL股权反转可能性…湖畔面前面临的三大壁垒 https://mtimes.net/zh/article/1441 MTIMES Global zh-cn 2026-11-04T01:07:04.381Z AMD数据中心营收飙升97% 预计第四季度营收达170亿美元 https://mtimes.net/zh/article/1420 MTIMES Global zh-cn 2026-11-02T04:47:16.797Z 韩华打入美军舰市场：斥资50亿美元扩大美国造船业规模 https://mtimes.net/zh/article/1408 MTIMES Global zh-cn 2026-11-01T00:44:02.307Z Anthropic拓宽AI业务至新药研发：从抗体优化到临床支持 https://mtimes.net/zh/article/1439 MTIMES Global zh-cn 2026-11-03T23:21:04.608Z HLB肝癌新药冲刺美国FDA正式审评：明年4月迎来第二次商业化分水岭 https://mtimes.net/zh/article/1450 MTIMES Global zh-cn 2026-11-05T02:53:26.322Z D&D Pharmatech将参加“2026欧洲生物医药展”，探讨UCN2靶向DD18等全球合作 https://mtimes.net/zh/article/1425 MTIMES Global zh-cn 2026-11-02T08:09:44.930Z 浦项控股筹集2.5万亿韩元弹药…加速锂投资与股东回报 https://mtimes.net/zh/article/1396 MTIMES Global zh-cn 2026-10-30T02:34:19.895Z 韩美半导体，即便HBM市场火热也难逃“财报冲击”…第四季度能否反弹？